HITS Inc.
PrivateLast Round
Series A
Extension
Nov 13, 2025
Total Funding Raised
$13.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HITS Inc. is a biotechnology company that provides an AI platform for drug discovery, integrating physics and deep learning to accelerate the identification and design of new drug compounds.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HITS Inc. Comparables
Compare HITS Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 85% | |
| Aigen Sciences | 83% | |
| Optibrium | 81% |
HITS Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 13, 2025 | ||||
| Series A | Feb 14, 2022 | ||||
| Seed | Oct 1, 2020 |
HITS Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series A Extension, Seed, Series A |
| Company K Partners | Series A |
| Schmidt | Seed |
| Kiwoom Investment | Series A Extension, Series A |
| Capstone Partners Korea | Series A |
| STIC Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 48, 2.5x the trailing average.
- May 1, 2026
Launched HyperLab, an AI drug development SaaS platform.
HITS Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HITS Inc.'s valuation, stock price, and market status.
Is HITS Inc. a public or private company?
HITS Inc. is a private company.
What is the current stock price of HITS Inc.?
HITS Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is HITS Inc. worth (valuation)?
Valuation information for HITS Inc. is not publicly available.
Can I buy HITS Inc. stock?
HITS Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HITS Inc.'s last funding round?
HITS Inc.'s most recent funding round was Series A Extension on November 13, 2025.
Who are the main investors in HITS Inc.?
Key investors in HITS Inc. include Korea Investment Partners.
Will HITS Inc. IPO soon?
No public IPO plans have been announced for HITS Inc..
How can I track HITS Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HITS Inc.'s secondary market activity and sign up for updates.